Brand-name vs compounded
Hers vs TMates: Brand-Name or Compounded? (2026)
Hers $149/mo vs TMates $199/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.8 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Comparing Hers with TMates means comparing two business models more than two medications. The molecules overlap; the terms do not.
The dividing line is regulatory, not cosmetic: Hers works with product the FDA has reviewed and approved, while TMates runs on compounded medication prepared by a pharmacy rather than manufactured under an approved application. Everything else about the two — price, support, shipping — follows from that decision.
Everything here is drawn from each provider's own published pricing and program detail, then extended into six- and twelve-month totals so the two become comparable. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Lowest 12-month cost
- Hers — $1,788 against $2,388 at TMates, on each provider's own best published pricing.
- FDA-approved medication
- Hers — FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — a finished product the FDA has reviewed, rather than a compounded preparation.
- Quickest to start
- TMates — Virtual check-in appointments, then medication formulated in U.S. facilities.
- Longest public track record
- TMates — 21,970 patient reviews against 6,200.
The short version: Hers vs TMates
Read the second row before the first: the advertised price and the price you actually run at are frequently different numbers.
| Hers | TMates | |
|---|---|---|
| Advertised price | Wegovy pill from $149/mo, injectable from $199/mo | $199/mo at every dose, no step-up fees |
| Rate after promotions | $149/mo | $199/mo |
| Pricing structure | Published rate per medication | Flat rate at every dose |
| Medication | FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen | Compounded semaglutide |
| Tirzepatide | Not published | Not published |
| Price transparency | Published upfront | Published upfront |
| Shipping | Home delivery, no insurance required | Medication formulated in U.S. facilities |
| Support model | Provider check-ins included | Provider check-ins included |
| Patient reviews | 6,200 | 21,970 |
| eRxDoctor score | 9.8/10 | 7.0/10 |
Hers vs TMates on total cost, not entry price
Almost every complaint about telehealth GLP-1 pricing traces back to comparing month one instead of month twelve. The figures underneath convert both offers into what you will have spent by month six and month twelve.
| Hers | TMates | |
|---|---|---|
| First month | $149 | $199 |
| Months 2 onward | $149/mo | $199/mo |
| 6-month total | $894 | $1,194 |
| 12-month total | $1,788 | $2,388 |
| Best published plan | No multi-month discount published | No multi-month discount published |
Over a year that is a $600 difference, in Hers's favor. Whether it is the right call depends on whether TMates gives you $50 a month of something you will use.
Brand-name product versus a pharmacy preparation
On Hers's side of the line sits FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen — product manufactured under an approved application, with the batch-to-batch consistency that approval requires.
TMates works with compounded semaglutide. Compounding is what puts $199/mo within reach; it also means no approval application stands behind the specific product you receive.
Neither choice is wrong, but they are different risks. Paying $149/mo buys regulatory certainty. Paying less buys access, on terms where the manufacturing oversight is not the same.
Inside the Hers program
Hers offers FDA-approved Wegovy® (brand-name semaglutide) with a personalized care team and ongoing dose check-ins, no compounded medications. In this pairing, its distinguishing feature is brand-name Wegovy at a price that usually buys compounded medication elsewhere.
From signup to first shipment: online intake with clinician review, then home delivery, no insurance required. Billing follows a published rate per medication structure.
Behind the prescription sits personalized care team with ongoing dose check-ins. Available medication: FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen.
Hers pros
- No insurance required
- Personalized care team with ongoing dose check-ins
- FDA-approved brand-name Wegovy®, not a compounded product
Hers cons
- Higher starting price than most compounded competitors
- No compounded/generic alternative offered
The cost of choosing this over TMates: there is no compounded tier to fall back on if the brand-name price stops working for you.
TMates in detail
$199/month, every dose, no step-up fees What it is really selling here is one flat $199 that survives every titration step, with doctors rather than a message queue behind it.
Practically: virtual check-in appointments, medication formulated in U.S. facilities, and a pricing model that is flat rate at every dose.
Ongoing care is 24/7 access to U.S.-based doctors, not just messaging, and the medication list runs to compounded semaglutide.
TMates pros
- Virtual check-in appointments for ongoing medical oversight
- Licensed coverage in all 50 states
- Medications formulated in U.S.-based facilities
- Flat $199/month at every dose, no step-up fees as dosage escalates
TMates cons
- No branded Ozempic, Wegovy, or Zepbound
- Compounded semaglutide only, limited public detail on tirzepatide availability
- $199/month is higher than the cheapest compounded options
The reservation worth holding, particularly next to Hers: semaglutide only, and $199 is well above the cheapest compounded options.
Who should choose Hers, and who should choose TMates
Choose Hers if:
- you want to start on their timeline: online intake with clinician review
- the level of clinical contact suits you: personalized care team with ongoing dose check-ins
- delivery works the way you want it to: home delivery, no insurance required
- you want an FDA-approved finished medication rather than a compounded preparation
Choose TMates if:
- delivery works the way you want it to: medication formulated in U.S. facilities
- you want to start on their timeline: virtual check-in appointments
- the level of clinical contact suits you: 24/7 access to U.S.-based doctors, not just messaging
- the feature you would actually use: one flat $199 that survives every titration step, with doctors rather than a message queue behind it
Where each program concedes something
On price. The monthly gap is 34% in Hers's favor. Whether that is a saving or a false economy turns on one thing: there is no compounded tier to fall back on if the brand-name price stops working for you.
On medication. Hers covers FDA-approved Wegovy pill (oral semaglutide) and Wegovy injectable pen; TMates covers compounded semaglutide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
On clinical contact. The support models differ — personalized care team with ongoing dose check-ins against 24/7 access to U.S.-based doctors, not just messaging — and that difference is felt in week two, not week one.
On predictability. The pricing structures differ (published rate per medication versus flat rate at every dose), and structure, not headline rate, determines the twelve-month bill.
Evidence and regulatory status
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
The FDA has published specific concerns about unapproved GLP-1 drugs sold for weight loss, including dosing errors made when patients measure their own doses, per FDA.
The FDA maintains a standing page on medications containing semaglutide, including what separates an approved product from a copy, per FDA.
Use it as the floor for the conversation with whichever prescriber you end up with, rather than as a reason to pick one platform over the other.
Hers vs TMates: common questions
Which costs less over a year, Hers or TMates?
Hers, at roughly $1,788 for twelve months against $2,388 at TMates, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Is Hers cheaper than TMates?
Yes, on the ongoing rate. Hers runs $149/mo once promotional pricing ends, against $199/mo at TMates — a difference of 34%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which has more patient reviews, Hers or TMates?
TMates, with 21,970 against 6,200. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do Hers or TMates take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
How fast can I start with Hers compared with TMates?
Hers advertises online intake with clinician review, with home delivery, no insurance required. TMates advertises virtual check-in appointments, with medication formulated in U.S. facilities. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Can I switch from Hers to TMates later?
Yes. Neither program locks you in clinically, and both operate month to month unless you have bought a multi-month plan. Practically, switching means a fresh intake, a fresh clinician review and possibly a gap in supply, so time it against your current shipment rather than your renewal date.
Do Hers and TMates prescribe the same medication?
No. Hers dispenses brand-name, FDA-approved finished medication; TMates dispenses compounded medication prepared by a pharmacy rather than manufactured under an approved application. That is a regulatory difference rather than a branding one, and it is the main reason the two prices are not directly comparable.
The verdict
Hers is the cheaper year by $600, and for a straightforward course of treatment that settles it.
Where TMates justifies itself is one flat $199 that survives every titration step, with doctors rather than a message queue behind it. Where it does not is anywhere the extra spend buys features you will never open.
Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.
Keep comparing
- Hers vs altRxBrand-name vs compounded
- Hers vs Yucca HealthBrand-name vs compounded
- Enhance MD vs TMatesBudget vs premium
- altRx vs TMatesBudget vs premium
- Ro.co vs MaximusBrand-name vs compounded
- Enhance MD vs Ro.coBrand-name vs compounded
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Hers or TMates, and does not sell treatment. Read our ranking methodology.